These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 24699883)
21. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Schuetz P; Müller B; Christ-Crain M; Stolz D; Tamm M; Bouadma L; Luyt CE; Wolff M; Chastre J; Tubach F; Kristoffersen KB; Burkhardt O; Welte T; Schroeder S; Nobre V; Wei L; Bhatnagar N; Bucher HC; Briel M Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD007498. PubMed ID: 22972110 [TBL] [Abstract][Full Text] [Related]
22. The clinical usefulness of procalcitonin measurement for assessing the severity of bacterial infection in critically ill patients requiring corticosteroid therapy. Kushimoto S; Shibata Y; Koido Y; Kawai M; Yokota H; Yamamoto Y J Nippon Med Sch; 2007 Jun; 74(3):236-40. PubMed ID: 17625373 [TBL] [Abstract][Full Text] [Related]
23. [Antibiotic treatment of surgical intensive care patients: procalcitonin to guide duration of therapy]. Hochreiter M; Köhler T; Schweiger AM; Keck FS; Bein B; von Spiegel T; Schröder S Anaesthesist; 2008 Jun; 57(6):571-7. PubMed ID: 18463831 [TBL] [Abstract][Full Text] [Related]
24. Procalcitonin-guided algorithm to reduce length of antibiotic therapy in patients with severe sepsis and septic shock. Hohn A; Schroeder S; Gehrt A; Bernhardt K; Bein B; Wegscheider K; Hochreiter M BMC Infect Dis; 2013 Apr; 13():158. PubMed ID: 23547790 [TBL] [Abstract][Full Text] [Related]
25. Calcitonin and procalcitonin in patients with medullary thyroid cancer or bacterial infection. Kaczka K; Mikosiński S; Fendler W; Celnik A; Pomorski L Adv Clin Exp Med; 2012; 21(2):169-78. PubMed ID: 23214280 [TBL] [Abstract][Full Text] [Related]
26. Role of procalcitonin in managing adult patients with respiratory tract infections. Schuetz P; Amin DN; Greenwald JL Chest; 2012 Apr; 141(4):1063-1073. PubMed ID: 22474148 [TBL] [Abstract][Full Text] [Related]
27. [Serum procalcitonin: a reliable tool for the diagnosis and follow-up of neonatal bacterial infections in Sub-Saharan Africa]. Alima Yanda AN; Kobela M; Nansseu JR; Taguebue J; Boula A; Eposse C; Monono N; Ngo Um-Sap S; Gervaix A; Koki Ndombo PO Arch Pediatr; 2015 Oct; 22(10):1015-20. PubMed ID: 26160140 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of procalcitonin in the early diagnosis of bacterial infections in a critical care unit. Nakamura A; Wada H; Ikejiri M; Hatada T; Sakurai H; Matsushima Y; Nishioka J; Maruyama K; Isaji S; Takeda T; Nobori T Shock; 2009 Jun; 31(6):586-91. PubMed ID: 19060784 [TBL] [Abstract][Full Text] [Related]
29. Survey of serum procalcitonin in cirrhotic patients. Rahimkhani M; Einollahi N; Khavari Daneshvar H; Dashti N Acta Med Iran; 2013 Apr; 51(3):153-6. PubMed ID: 23605598 [TBL] [Abstract][Full Text] [Related]
30. Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial. Verduri A; Luppi F; D'Amico R; Balduzzi S; Vicini R; Liverani A; Ruggieri V; Plebani M; Barbaro MP; Spanevello A; Canonica GW; Papi A; Fabbri LM; Beghè B; PLoS One; 2015; 10(3):e0118241. PubMed ID: 25760346 [TBL] [Abstract][Full Text] [Related]
31. Procalcitonin: a new marker for diagnosis of acute rejection and bacterial infection in patients after heart and lung transplantation. Hammer S; Meisner F; Dirschedl P; Höbel G; Fraunberger P; Meiser B; Reichardt B; Hammer C Transpl Immunol; 1998 Dec; 6(4):235-41. PubMed ID: 10342737 [TBL] [Abstract][Full Text] [Related]
32. Procalcitonin in intensive care units: the PRORATA trial. Mokart D; Leone M Lancet; 2010 May; 375(9726):1605; author reply 1606-7. PubMed ID: 20452515 [No Abstract] [Full Text] [Related]
33. Procalcitonin in intensive care units: the PRORATA trial. Tarnow-Mordi W; Gebski V Lancet; 2010 May; 375(9726):1605; author reply 1606-7. PubMed ID: 20452513 [No Abstract] [Full Text] [Related]
34. Procalcitonin in intensive care units: the PRORATA trial. Gibot S Lancet; 2010 May; 375(9726):1605-6; author reply 1606-7. PubMed ID: 20452514 [No Abstract] [Full Text] [Related]
35. Structure and diagnostic value of procalcitonin. Floriańczyk B Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):338-42. PubMed ID: 15315011 [TBL] [Abstract][Full Text] [Related]
36. Can procalcitonin monitoring reduce the length of antibiotic treatment in bloodstream infections? Pantelidou IM; Giamarellos-Bourboulis EJ Int J Antimicrob Agents; 2015 Dec; 46 Suppl 1():S10-2. PubMed ID: 26686272 [TBL] [Abstract][Full Text] [Related]
37. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial. Shehabi Y; Sterba M; Garrett PM; Rachakonda KS; Stephens D; Harrigan P; Walker A; Bailey MJ; Johnson B; Millis D; Ding G; Peake S; Wong H; Thomas J; Smith K; Forbes L; Hardie M; Micallef S; Fraser JF; ; Am J Respir Crit Care Med; 2014 Nov; 190(10):1102-10. PubMed ID: 25295709 [TBL] [Abstract][Full Text] [Related]
38. The Comparison of Procalcitonin Guidance Administer Antibiotics with Empiric Antibiotic Therapy in Critically Ill Patients Admitted in Intensive Care Unit. Najafi A; Khodadadian A; Sanatkar M; Shariat Moharari R; Etezadi F; Ahmadi A; Imani F; Khajavi MR Acta Med Iran; 2015; 53(9):562-7. PubMed ID: 26553084 [TBL] [Abstract][Full Text] [Related]
39. Procalcitonin (PCT) is useful in predicting the bacterial origin of an acute circulatory failure in critically ill patients. Cheval C; Timsit JF; Garrouste-Orgeas M; Assicot M; De Jonghe B; Misset B; Bohuon C; Carlet J Intensive Care Med; 2000 Mar; 26 Suppl 2():S153-8. PubMed ID: 18470711 [TBL] [Abstract][Full Text] [Related]
40. Applying biomarkers to clinical practice: a guide for utilizing procalcitonin assays. Foushee JA; Hope NH; Grace EE J Antimicrob Chemother; 2012 Nov; 67(11):2560-9. PubMed ID: 22833636 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]